Pancreatic Cancer Research

ResearcherSpanish National Cancer Research CentreActive in the last 2 years

Enza Lonardo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6654-1043; OpenAlex author ID A5043067889. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 3 papers

Papers 16

  1. AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.08.021↗
  2. Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41392-025-02546-8↗
  3. Mechanobiology-guided drug repurposing identifies budesonide as an inhibitor of stiffness-induced PDAC aggressiveness Co-author DOI 10.64898/2026.07.17.739125↗
  4. TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and … Last author DOI 10.1038/s41419-025-07859-8↗
  5. A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening. Co-author DOI 10.1002/adhm.202401138↗
  6. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism. Co-author DOI 10.1186/s13046-024-03072-1↗
  7. Editorial: Stem cells in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1248807↗
  8. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. Last author DOI 10.1186/s13046-022-02516-w↗
  9. The Revolutionary Roads to Study Cell-Cell Interactions in 3D In Vitro Pancreatic Cancer Models. Last author DOI 10.3390/cancers13040930↗
  10. TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Last author DOI 10.1038/s41388-020-1289-1↗
  11. A synergic approach to enhance long-term culture and manipulation of MiaPaCa-2 pancreatic cancer spheroids. Co-author DOI 10.1038/s41598-020-66908-8↗
  12. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Co-author DOI 10.1136/gutjnl-2014-308470↗
  13. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. Co-author DOI 10.3791/52801↗
  14. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. Co-author DOI 10.1371/journal.pone.0076518↗
  15. Pancreatic cancer stem cells: new insights and perspectives. First author DOI 10.1007/s00535-011-0422-x↗
  16. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Co-author DOI 10.1016/j.stem.2011.10.001↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donatella Delle Cave · 7 shared papers, 2020–2025 · strength 1.11
  2. Bruno Sáinz · 6 shared papers, 2015–2026 · strength 0.95
  3. Gabriella Minchiotti · 3 shared papers, 2024–2026 · strength 0.62
  4. Loretta L. del Mercato · 3 shared papers, 2020–2024 · strength 0.51
  5. Christopher Heeschen · 7 shared papers, 2011–2022 · strength 0.44
  6. Cristina D’Aniello · 2 shared papers, 2024–2026 · strength 0.43
  7. Eduardo Ibello · 2 shared papers, 2024–2026 · strength 0.43
  8. Alessandro Carrer · 2 shared papers, 2022–2025 · strength 0.31
  9. Paola Cappello · 1 shared paper, 2026 · strength 0.30
  10. Silvia Carrara · 1 shared paper, 2026 · strength 0.30
  11. Claudio Luchini · 1 shared paper, 2026 · strength 0.30
  12. Manuel Gentiluomo · 1 shared paper, 2026 · strength 0.30
  13. Federica Marchesi · 1 shared paper, 2026 · strength 0.30
  14. Elisa Giovannetti · 1 shared paper, 2026 · strength 0.30
  15. Salvatore Paiella · 1 shared paper, 2026 · strength 0.30
  16. Simone Mas · 1 shared paper, 2026 · strength 0.26
  17. Paolo A. Netti · 1 shared paper, 2026 · strength 0.26
  18. Rosaria Benedetti · 1 shared paper, 2026 · strength 0.23
  19. Ferdinando De Vita · 1 shared paper, 2026 · strength 0.23
  20. Ugo Chianese · 1 shared paper, 2026 · strength 0.23
  21. Stefania Forciniti · 1 shared paper, 2024 · strength 0.22
  22. Anna Chiara Siciliano · 1 shared paper, 2024 · strength 0.22
  23. Michele Cioffi · 3 shared papers, 2013–2015 · strength 0.15
  24. Marta Cavo · 1 shared paper, 2020 · strength 0.13
  25. Jorge Dorado · 3 shared papers, 2011–2015 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.